Department of Obstetrics and Gynaecology, University Hospital of Würzburg, D-97080 Würzburg, Germany.
Department of Radiation Oncology, Leopoldina Hospital Schweinfurt, D-97422 Schweinfurt, Germany.
Nutrients. 2021 Mar 23;13(3):1029. doi: 10.3390/nu13031029.
Breast cancer (BC) patients often ask for a healthy diet. Here, we investigated a healthy standard diet (SD), a low carb diet (LCD), and a ketogenic diet (KD) for BC patients during the rehabilitation phase. KOLIBRI was an open-label non-randomized one-site nutritional intervention trial, combining inpatient and outpatient phases for 20 weeks. Female BC patients ( = 152; mean age 51.7 years) could select their diet. Data collected were: Quality of life (QoL), spiroergometry, body composition, and blood parameters. In total 30, 92, and 30 patients started the KD, LCD, and SD, respectively. Of those, 20, 76, and 25 completed the final examination. Patients rated all diets as feasible in daily life. All groups enhanced QoL, body composition, and physical performance. LCD participants showed the most impressive improvement in QoL aspects. KD participants finished with a very good physical performance and muscle/fat ratio. Despite increased cholesterol levels, KD patients had the best triglyceride/high-density lipoprotein (HDL) ratio and homeostatic model assessment of insulin resistance index (HOMA-IR). Most metabolic parameters significantly improved in the LCD group. SD participants ended with remarkably low cholesterol levels but did not improve triglyceride/HDL or HOMA-IR. In conclusion, both well-defined KDs and LCDs are safe and beneficial for BC patients and can be recommended during the rehabilitation phase.
乳腺癌(BC)患者经常寻求健康饮食。在这里,我们研究了康复阶段 BC 患者的健康标准饮食(SD)、低碳水化合物饮食(LCD)和生酮饮食(KD)。KOLIBRI 是一项开放标签、非随机、单站点营养干预试验,结合了 20 周的住院和门诊阶段。女性 BC 患者(n=152;平均年龄 51.7 岁)可以选择自己的饮食。收集的数据包括:生活质量(QoL)、呼吸量测定法、身体成分和血液参数。共有 30、92 和 30 名患者分别开始了 KD、LCD 和 SD,其中 20、76 和 25 名患者完成了最终检查。患者认为所有饮食在日常生活中都是可行的。所有组均提高了 QoL、身体成分和身体表现。LCD 组患者的 QoL 方面改善最为显著。KD 组患者完成时的身体表现和肌肉/脂肪比非常好。尽管胆固醇水平升高,但 KD 患者的甘油三酯/高密度脂蛋白(HDL)比值和稳态模型评估的胰岛素抵抗指数(HOMA-IR)最佳。大多数代谢参数在 LCD 组中显著改善。SD 组患者的胆固醇水平显著降低,但甘油三酯/HDL 或 HOMA-IR 没有改善。总之,明确的 KD 和 LCD 对 BC 患者既安全又有益,并可在康复阶段推荐。